Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
  1. 4 Shares withheld for taxes Director gave up 293 shares (to pay taxes)
  2. 4 Shares withheld for taxes Director gave up 54 shares (to pay taxes)
  3. 4 Shares withheld for taxes Director gave up 123 shares (to pay taxes)
  4. 4 Grant or award Chief Accounting Officer acquired 38,685 shares (grant or award)
  5. 4 Grant or award CFO acquired 38,685 shares (grant or award)
  6. 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
  7. 4 Shares withheld for taxes CFO gave up 8,515 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Accounting Officer gave up 9,881 shares (to pay taxes)
  9. 4 Shares withheld for taxes President & COO gave up 16,002 shares (to pay taxes)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
  12. 4 Shares withheld for taxes Pres&Chief Investment Officer gave up 366,211 shares (to pay taxes)
  13. 4 Shares withheld for taxes CEO gave up 215,991 shares (to pay taxes)
  14. 4 Shares withheld for taxes President & COO gave up 16,003 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Accounting Officer gave up 1,506 shares (to pay taxes)
  16. 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
  17. 4 Other disposition Director disposed of 30,257,723 shares (other)
  18. 4 Other disposition Director disposed of 45,821,757 shares (other)
  19. 4 Other disposition 10% owner disposed of 45,821,757 shares (other)
  20. 4 Shares withheld for taxes CFO gave up 1,630 shares (to pay taxes)

Page 13 of 26 · 511 filings